Provided by Tiger Fintech (Singapore) Pte. Ltd.

BridgeBio Pharma, Inc.

33.51
-0.3600-1.06%
Pre-market: 34.000.4900+1.46%07:09 EDT
Volume:1.50M
Turnover:50.45M
Market Cap:6.37B
PE:-11.64
High:34.29
Open:33.68
Low:33.21
Close:33.87
Loading ...
Sep 05, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 03, 2023

Major Issues Report

Form 8-K - Current report
Aug 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 20, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jul 18, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 17, 2023

Major Issues Report

Form 8-K - Current report
Jun 23, 2023

Major Issues Report

Form 8-K - Current report
May 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 04, 2023

Major Issues Report

8-K - Current report
May 04, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 04, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 04, 2023

Major Issues Report

8-K - Current report
May 03, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 05, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 09, 2023

Major Issues Report

8-K - Current report
Mar 06, 2023

Major Issues Report

8-K - Current report
Feb 23, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]